Anagenics Ltd has released a press release.
MK antibody publication and patent in bone healing
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Anagenics
- Midkine Strategy Update
- Response to ASX Query
- Cellmid to Refinance RnD Loan
- Cellmid receives $1.12M R&D Tax Credit
- Key Antibody Patent Granted in Europe
Later from Anagenics
- USA Distribution Partnership for Cellmids Evolis
- CDY: Ikon Legal Action
- Transcript of Cellmid Investor Briefing Call
- New Publication for Cellmids Midkine Antibody
- European Midkine Patent For Surgical Adhesion Allowed
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics